Loading…
Lobbying Spend
—
Filings
75
Firms Hired
2
Active Period
1999–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Department of Defense Appropriations Act, 2023
2022 · second_quarter · Firm: GALILEO CONSULTING GROUP, INC.
Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - H.R.8236 - Department of Defense Appropriations Act, 2023 Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as a new Peer Reviewed Cancer Program or to the list of eligible cancers - HR 8236 - Department of Defense Appropriations Act, 2023 Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - Department of Defense Appropriations Act - Senate Dear Colleague Letters and Report Language Submissions Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as its own line-item program for FY 2023 - Senate Dear Colleague Letters and Report Language Submissions
Client expense: — · Firm income: $20,000
Matched citations: H.R.8236, HR 8236
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
2022 · second_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2023 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client expense: — · Firm income: $20,000
Matched citations: H.R.8295
PREVENT HPV Cancers Act of 2021
2022 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - HR 2471 Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: HR 1550
Jeanette Acosta Invest in Women’s Health Act of 2021
2022 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - HR 2471 Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2216
Consolidated Appropriations Act, 2022
2022 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - HR 2471 Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: HR 2471
Consolidated Appropriations Act, 2022
2022 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022 and HR 2471 - Consolidated Appropriations Act of 2022 Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432 and HR 2471 - Consolidated Appropriations Act of 2022 Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - Department of Defense Appropriations Act - Dear Colleague Letters and Report Language Submissions Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as its own line-item program for FY 2023 - Dear Colleague Letters and Report Language Submissions
Client expense: — · Firm income: $20,000
Matched citations: HR 2471
Department of Defense Appropriations Act, 2022
2022 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022 and HR 2471 - Consolidated Appropriations Act of 2022 Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432 and HR 2471 - Consolidated Appropriations Act of 2022 Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - Department of Defense Appropriations Act - Dear Colleague Letters and Report Language Submissions Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as its own line-item program for FY 2023 - Dear Colleague Letters and Report Language Submissions
Client expense: — · Firm income: $20,000
Matched citations: HR 4432
Jeanette Acosta Invest in Women’s Health Act of 2021
2022 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - HR 2471 Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: S. 1063
PREVENT HPV Cancers Act of 2021
2021 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: HR 1550
Jeanette Acosta Invest in Women’s Health Act of 2021
2021 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2216
Department of Defense Appropriations Act, 2022
2021 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022 Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432
Client expense: — · Firm income: $20,000
Matched citations: HR 4432
Jeanette Acosta Invest in Women’s Health Act of 2021
2021 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: S. 1063
Protecting Medicare and American Farmers from Sequester Cuts Act
2021 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
Medicare Physician Fee Schedule Payments for 2022 - Update to the Conversion Factor. S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act
Client expense: — · Firm income: $20,000
Matched citations: S. 610
PREVENT HPV Cancers Act of 2021
2021 · third_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: HR 1550
Jeanette Acosta Invest in Women’s Health Act of 2021
2021 · third_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2216
Department of Defense Appropriations Act, 2022
2021 · third_quarter · Firm: GALILEO CONSULTING GROUP, INC.
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022 Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432
Client expense: — · Firm income: $20,000
Matched citations: HR 4432
Jeanette Acosta Invest in Women’s Health Act of 2021
2021 · third_quarter · Firm: GALILEO CONSULTING GROUP, INC.
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063) PREVENT HPV Cancers Act (HR 1550)
Client expense: — · Firm income: $20,000
Matched citations: S. 1063
American Rescue Plan Act of 2021
2021 · second_quarter · Firm: GALILEO CONSULTING GROUP, INC.
-- FY 2022 federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act: Report language on gynecological cancer and disparities research -- H.R. 1319 - American Rescue Plan Act of 2021: COVID-19 policies and funding
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1319
Department of Defense Appropriations Act, 2022
2021 · second_quarter · Firm: GALILEO CONSULTING GROUP, INC.
H.R. 4432 - Department of Defense Appropriations Act, 2022: Ovarian Cancer Research Program at the Department of Defense; Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers
Client expense: — · Firm income: $20,000
Matched citations: H.R. 4432
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
-- FY 2022 federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act: Report language on gynecological cancer and disparities research -- H.R. 1319 - American Rescue Plan Act of 2021: COVID-19 policies and funding
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1319
To prevent across-the-board direct spending cuts, and for other purposes.
2021 · first_quarter · Firm: GALILEO CONSULTING GROUP, INC.
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes: Extends a suspension of Medicare sequestration and makes other technical changes to Medicare payments and Medicaid eligibility
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1868
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage -- H.R. 913 / S. 4742 - Medical Treatment Act: Coverage by Medicaid of clinical trials -- H.R. 133 - Consolidated Appropriations Act, 2021; H.R. 8702 / S. 5007 - Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020; H.R. 8505 - To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes: Medicare Evaluation and Management Visits - Addressing the impact of E/M services updates on the future of the conversion factor and the payments for other Medicare services; discussions of various policy change proposals to address the budget neutrality of these payment changes
Client expense: — · Firm income: $30,000
Matched citations: H.R. 133
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
-- H.R. 133 - Consolidated Appropriations Act, 2021: Ovarian Cancer Research Program at the Department of Defense; letters to Appropriations Committees; Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers, FY 2021 Report
Client expense: — · Firm income: $30,000
Matched citations: H.R. 133
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
-- H.R. 133 - Consolidated Appropriations Act, 2021: FY 2021 Federal research funding for Gynecologic Cancer Clinical Trials in the Departments of Labor, HHS and Education Appropriations Act
Client expense: — · Firm income: $30,000
Matched citations: H.R. 133
Improving Seniors’ Timely Access to Care Act of 2019
2020 · fourth_quarter · Firm: GALILEO CONSULTING GROUP, INC.
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage -- H.R. 913 / S. 4742 - Medical Treatment Act: Coverage by Medicaid of clinical trials -- H.R. 133 - Consolidated Appropriations Act, 2021; H.R. 8702 / S. 5007 - Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020; H.R. 8505 - To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes: Medicare Evaluation and Management Visits - Addressing the impact of E/M services updates on the future of the conversion factor and the payments for other Medicare services; discussions of various policy change proposals to address the budget neutrality of these payment changes
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3107
Source: Senate LDA